Description

Several oncoproteins, such as androgen receptor, estrogen receptor, ERRa, and BRD4, have been specifically ubiquitinated and destroyed via PROTACs, which function as bridges between the target protein and an E3 ligase. Peptide modulators exhibit greater potential than small-molecule drugs in several important aspects. Peptide modulators could significantly facilitate the modification of drugs and target protein-protein interactions, which are difficult to accomplish via small molecules.

BOC Sciences is specialized in the process development and the manufacturing of bioactive peptides. We are dedicated to offering services like custom peptide synthesis, process development, GMP manufacturing as well as catalog products for customers in both industry and academia.